Post-marketing Drug Safety Evaluation Using Data Mining Based on FAERS
Healthcare is going through a big data revolution. The amount of data generated by healthcare is expected to increase significantly in the coming years. Therefore, efficient and effective data processing methods are required to transform data into information. In addition, applying statistical analysis can transform the information into useful knowledge. We developed a data mining method that can uncover new knowledge in this enormous field for clinical decision making while generating scientific methods and hypotheses. The proposed pipeline can be generally applied to a variety of data mining tasks in medical informatics. For this study, we applied the proposed pipeline for post-marketing surveillance on drug safety using FAERS, the data warehouse created by FDA. We used 14 kinds of neurology drugs to illustrate our methods. Our result indicated that this approach can successfully reveal insight for further drug safety evaluation.
KeywordsData mining Post-marketing surveillance Zero-truncated negative binomial regression model
This research was partially supported by the National Library of Medicine of the National Institutes of Health under Award Number R01LM011829, the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI130460, and the UTHealth Innovation for Cancer Prevention Research Training Program Pre-doctoral Fellowship (Cancer Prevention and Research Institute of Texas grant # RP160015).
- 1.Nambiar, R., Bhardwaj, R., Sethi, A., et al.: A look at challenges and opportunities of big data analytics in healthcare. In: 2013 IEEE International Conference on Big Data, pp. 17–22 (2013)Google Scholar
- 3.Food and Drug Administration (FDA), Questions and Answers on FDA’s Adverse Event Reporting System (FAERS). http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/
- 7.Xu, J., Wu, Y., Zhang, Y., Wang, J., Lee, H.J., Xu, H.: CD-REST: a system for extracting chemical-induced disease relation in literature, Database (Oxford) (2016)Google Scholar
- 8.Drugs.com. https://www.drugs.com/
- 9.Medical Dictionary for Regulatory Activities. http://www.meddra.org/how-to-use/support-documentation
- 11.Medical Dictionary for Regulatory Activities. http://www.who.int/medical_devices/innovation/MedDRAintroguide_version14_0_March2011.pdf